Cronos group - The Trending News

Web portal. Search, collect, analyze news, info & data from Internet by lambaro.info

Top News Headlines

Reviewing Stemline Therapeutics Inc. (STML)'s and Cronos Group Inc. (NASDAQ:CRON)'s results
Stemline Therapeutics Inc. (NASDAQ:STML) and Cronos Group Inc. (NASDAQ:CRON) compete with each other in the Biotechnology sector. We will analyze…
Aug 15, 2019 10:06 UTC Read More

Comparison of NewLink Genetics Corporation (NLNK) and Cronos Group Inc. (NASDAQ:CRON)
This is a contrast between NewLink Genetics Corporation (NASDAQ:NLNK) and Cronos Group Inc. (NASDAQ:CRON) based on their institutional ownership,…
Aug 14, 2019 20:27 UTC Read More

Contrasting of Cronos Group Inc. (CRON) and Aimmune Therapeutics Inc. (NASDAQ:AIMT)
Both Cronos Group Inc. (NASDAQ:CRON) and Aimmune Therapeutics Inc. (NASDAQ:AIMT) compete on a level playing field in the Biotechnology industry.
Aug 14, 2019 02:18 UTC Read More

Reviewing Cyclerion Therapeutics Inc. (CYCN)'s and Cronos Group Inc. (NASDAQ:CRON)'s results
We will be comparing the differences between Cyclerion Therapeutics Inc. (NASDAQ:CYCN) and Cronos Group Inc. (NASDAQ:CRON) as far as analyst…
Aug 12, 2019 17:40 UTC Read More

Cronos Group Inc (CRON) Chaikin Money Flow Showing Negative Signs
Cronos Group Inc (CRON) is seeing negative money flow as the Chalkin (CMF) indicator is holding below the zero line. The Chaikin Money Flow Indicator is an…
Aug 12, 2019 13:50 UTC Read More

Cronos Group (NASDAQ:CRON) Rating Increased to Buy at Zacks Investment Research
Zacks Investment Research upgraded shares of Cronos Group (NASDAQ:CRON) from a hold rating to a buy rating in a research note published on Friday,…
Aug 12, 2019 11:37 UTC Read More

Valeo Financial Advisors LLC Buys 2,522 Shares of Cronos Group Inc (NASDAQ:CRON)
Valeo Financial Advisors LLC grew its holdings in Cronos Group Inc (NASDAQ:CRON) by 6305.0% in the 2nd quarter, according to its most recent 13F filing with…
Aug 12, 2019 09:04 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Expected to Announce Earnings of $0.02 Per Share
Wall Street brokerages predict that Cronos Group Inc (NASDAQ:CRON) will report earnings of ($0.02) per share for the current fiscal quarter, according to Zacks.
Aug 12, 2019 04:41 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Shares Bought by Flagship Harbor Advisors LLC
Flagship Harbor Advisors LLC grew its holdings in Cronos Group Inc (NASDAQ:CRON) by 290.2% in the second quarter, according to its most recent disclosure…
Aug 11, 2019 16:52 UTC Read More

Cronos Group (NASDAQ:CRON) Upgraded to Buy by Zacks Investment Research
Cronos Group (NASDAQ:CRON) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday,…
Aug 11, 2019 12:32 UTC Read More

Cronos Group (NASDAQ:CRON) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
Cronos Group (NASDAQ:CRON) announced its quarterly earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter,…
Aug 11, 2019 11:23 UTC Read More

Cronos Group (TSE:CRON) Upgraded at Canaccord Genuity
Cronos Group (TSE:CRON) was upgraded by equities research analysts at Canaccord Genuity from a “sell” rating to a “hold” rating in a research report issued to…
Aug 11, 2019 10:52 UTC Read More

Bank of America Increases Cronos Group (NASDAQ:CRON) Price Target to $26.00
Cronos Group (NASDAQ:CRON) had its target price raised by Bank of America from $20.00 to $26.00 in a report released on Friday, Stock Target Advisor…
Aug 11, 2019 10:20 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Shares Acquired by Harel Insurance Investments & Financial Services Ltd.
Harel Insurance Investments & Financial Services Ltd. boosted its position in shares of Cronos Group Inc (NASDAQ:CRON) by 100.0% in the 2nd quarter,…
Aug 10, 2019 17:16 UTC Read More

Bank of America Boosts Cronos Group (NASDAQ:CRON) Price Target to $26.00
Cronos Group (NASDAQ:CRON) had its price target raised by equities research analysts at Bank of America from $20.00 to $26.00 in a note issued to investors…
Aug 10, 2019 11:22 UTC Read More

Cronos Group Inc (TSE:CRON) Given Consensus Rating of “Hold” by Brokerages
Shares of Cronos Group Inc (TSE:CRON) have been given a consensus recommendation of “Hold” by the eight ratings firms that are currently covering the stock,…
Aug 10, 2019 05:13 UTC Read More

Cronos Group Inc. (:CRON) Is on a Path to $15.04 According to Analysts
Investors might be trying to gauge which way shares of Cronos Group Inc. (:CRON) will swing over the next couple of quarters. In recent trading activity, the stock…
Aug 09, 2019 19:16 UTC Read More

Cronos Group Inc (CRON.TO): Technicals in Focus
The Percentage Price Oscillator has been recently spotted below the signal line on shares of Cronos Group Inc (CRON.TO). Traders watching these levels may…
Aug 09, 2019 16:35 UTC Read More

Buds & Duds: Cannabis stocks stumble on Friday; CannTrust shares sink as auditor withdraws report
Cannabis stocks sank on Friday, as the CannTrust scandal continued to rattle investor confidence in the sector. The North American Marijuana Index, which…
Aug 09, 2019 16:18 UTC Read More

Cronos Group Inc. (CRON): When The Market Gets It Wrong
The stock of Cronos Group Inc. (NASDAQ:CRON) has been Initiated to Equal Weight by Consumer Edge Research in its latest research note that was published…
Aug 09, 2019 15:40 UTC Read More

Cronos Group (NASDAQ:CRON) Upgraded at Canaccord Genuity
Cronos Group (NASDAQ:CRON) was upgraded by Canaccord Genuity from a “sell” rating to a “hold” rating in a research report issued to clients and investors on…
Aug 09, 2019 11:35 UTC Read More

$-0.02 EPS Expected for Cronos Group Inc. (CRON)
$-0.02 EPS Expected for Cronos Group Inc. (CRON). Finally, CIBC set a $30.00 target price on shares of Cronos Group and gave the company a "buy" rating in a…
Aug 09, 2019 11:05 UTC Read More

Giants In The NEWS: Cronos Group Inc. (NASDAQ:CRON)
On 07-August 2k19 (Wednesday), Shareholders tracking shares of Cronos Group Inc. (CRON) belongs to Healthcare sector and Biotechnology industry. CRON…
Aug 08, 2019 13:16 UTC Read More

Cookies

We may use cookies to give you the best experience. If you do nothing we'll assume that it's ok.

Terms & Privacy

The information forward from this site may be provided by third parties. We will not be responsible with outside links, contents from source of information, methods of using, using or consequence of contents with users. All direct or indirect risk related to use of this site is borne entirely by you, the user.

We use advertising companies as Google AdSense, to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, see https://policies.google.com/technologies/ads.